Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01404559 · ClinicalTrials.gov registry record · NA

Measures of Gait Efficiency of Three Multi-Axial, Vertical Shock and Energy Storing-Return Prosthetic Feet During Simple & Complex Mobility Activities

A NA study, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT01404559: Completed NA study, sponsored by University of South Florida.

NCT01404559 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01404559, a NA study, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

Many service members suffering major limb amputation(s) during active duty seek to return to active duty. The purpose of this study is to determine if biomechanic and/or bioenergtic differences exist between popular multi-function prosthetic feet that would facilitate return to duty for soldiers with amputations.

Primary Outcome

Laser timing lights were used to measure time necessary to complete a 17 task obstacle course. Participants trigger the laser timing lights when they run past them and the times are recorded in a laptop computer. Laser lights are set up in pairs at the beginning and end of the obstacle course.

Interventions

  • DEVICE Ossur Variflex prosthetic foot
  • DEVICE Ossur Ceterus prosthetic foot
  • DEVICE Endolite Elite Blade prosthetic foot

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2012-07
Est. Completion 2013-06
Phase NA
University of South Florida

252 total trials

What the finished NCT01404559 record still lists

NCT01404559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Ossur Variflex prosthetic foot is the first listed.

NCT01404559 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01404559 about?

NCT01404559 is a clinical study titled "Measures of Gait Efficiency of Three Multi-Axial, Vertical Shock and Energy Storing-Return Prosthetic Feet During Simple & Complex Mobility Activities". Many service members suffering major limb amputation(s) during active duty seek to return to active duty. The purpose of this study is to determine if biomechanic and/or bioenergtic differences exist between popular multi-function prosthetic feet that would facilitate return to duty for soldiers wit...

What is the current status of trial NCT01404559?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-07. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01404559?

The interventions under investigation include: Ossur Variflex prosthetic foot (DEVICE), Ossur Ceterus prosthetic foot (DEVICE), Endolite Elite Blade prosthetic foot (DEVICE).

Who is sponsoring clinical trial NCT01404559?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01404559's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01404559, the US trial registry maintained by the National Library of Medicine. NCT01404559 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.